Sodium apolate
{{Short description|Vasoprotective}}
{{cs1 config|name-list-style=vanc|display-authors=6}}
{{Drugbox
| IUPAC_name =
| image = Sodium apolate.svg
| width = 150
| tradename =
| pregnancy_AU =
| pregnancy_US =
| pregnancy_category =
| legal_AU =
| legal_CA =
| legal_UK =
| legal_US =
| legal_status =
| routes_of_administration =
| bioavailability =
| protein_bound =
| metabolism =
| elimination_half-life =
| excretion =
| CAS_number = 25053-27-4
| ATC_prefix = C05
| ATC_suffix = BA02
| PubChem = 3270262
| DrugBank =
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 9461405D9F
| KEGG = D04825
| ChemSpiderID = none
| chemical_formula = (C2H3NaO3S)n, with n~25
| molecular_weight =
}}
Sodium apolate (INN) or lyapolate sodium (USAN) is a vasoprotective.{{cite book | vauthors = Milne GW |url=https://books.google.com/books?id=QxcoEAAAQBAJ&dq=%22Sodium+apolate%22+-com+-net&pg=PA1039 |title=Drugs: Synonyms and Properties |date=2002-02-01 |publisher=John Wiley & Sons |isbn=978-0-566-08491-1 |language=en}}
References
{{Reflist}}{{Vasoprotectives}}
{{cardiovascular-drug-stub}}